Binance Launches 24/7 Foreign Exchange Perpetual Futures With 100x Leverage
Mark Van Oene, President & CEO of Pacific Biosciences of California, Inc. (), sold 26,911 shares of common stock on August 17, 2026. The transactions totaled $30,409, with shares sold at a weighted average price of $1.13, ranging from $1.13 to $1.15 per share.
